Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis-Reference-Cited by-同舟云学术

Biologics recommendations for patients with psoriasis: a critical appraisal of clinical practice guidelines for psoriasis

Published:2021-04-13 Issue: Volume: Page:1-36
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Xie Xiuli¹²³,Wang Yangyang¹²³,Yao Sha¹,Xia Yun⁴,Luo Hao⁴,Li Lui¹²³,Lu Chuanjian⁴⁵⁶

Affiliation:

1. Department of Standardization of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

2. Department of Standardization of Traditional Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China

3. Engineering and Technology Research Center of Standardization of Traditional Chinese Medicine, Guangzhou, Guangdong, China

4. School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China

5. Department of Dermatology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

6. Department of Dermatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2021.1914306

Reference70 articles.

1. Rachakonda TD, Schupp CW and Armstrong AW. Psoriasis prevalence among adults in the United States. Journal of the American Academy of Dermatology. 2014;70:512-6.

2. Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA dermatology. 2013;149:1173-9.

3. Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey. Am J Clin Dermatol. 2016;17(1):87-97.

4. Kurd SK, Troxel AB, Crits-Christoph P,et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8): 891-5.

5. Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013; 2(2):e000062.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

2. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis;Dermatologic Clinics;2024-07

3. Biological therapies for the treatment of psoriasis in pediatrics;Expert Opinion on Biological Therapy;2023-11-10

4. Is anti‐IL‐17 faster and anti‐IL‐23 better for psoriasis patients after adalimumab failure?;JEADV Clinical Practice;2023-11-06

5. Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients;Journal of the European Academy of Dermatology and Venereology;2023-05-04